-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Wave Life Sciences, Lowers Price Target to $15

Benzinga·11/12/2026 16:02:38
Listen to the news
Citigroup analyst Samantha Semenkow maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $19 to $15.